Table 4. Univariate and multivariate logistic regression analyses for factors associated with the presence of IR in RA patients.
| Univariate | Multivariate | |||||
| OR | 95% CI | p | OR | 95% CI | p | |
| Age (year) | 1.1 | 1.013-1.193 | 0.023 | 1.096 | 1.011-1.187 | 0.026 |
| Sex | 0.577 | 0.137-2.431 | 0.453 | 1.617 | 0.389-6.73 | 0.509 |
| Menopausal status | 0.552 | 0.013-23.739 | 0.757 | |||
| Body mass index | 1.286 | 0.98-1.688 | 0.07 | 1.258 | 0.969-1.633 | 0.085 |
| Disease duration (weeks) | 1.07 | 0.765-1.497 | 0.693 | |||
| DAS28 score | 6.003 | 1.638-22.005 | 0.007 | 5.75 | 1.754-18.844 | 0.004 |
| RF (IU/mL) | 1.001 | 0.999-1.002 | 0.505 | |||
| Anti-CCP (RU/mL) | 0.999 | 0.998-1.001 | 0.396 | 0.999 | 0.998-1.001 | 0.475 |
| C-reactive protein | 1.047 | 1.018-1.076 | 0.001 | 1.047 | 1.018-1.076 | 0.001 |
| Erythrocyte sedimentation rate | 0.983 | 0.954-1.013 | 0.265 | 0.981 | 0.953-1.011 | 0.213 |
| Using NSAIDs | 1.911 | 0.219-16.651 | 0.558 | |||
| IR: Insulin resistance; RA: Rheumatoid arthritis; CI: Confidence interval; DAS28: 28-joint disease activity score; RF: Rheumatoid factor; Anti-CCP: Anti-cyclic citrullinated peptide; NSAIDs, nonsteroidal anti-inflammatory drugs; Menopausal status is for female group. A p value <0.05 is considered as statistically significant. | ||||||